Novel hormone is safe and effective in men receiving radiotherapy for prostate cancer

Cancer. 2024 Jul 15;130(14):2408. doi: 10.1002/cncr.35422.
No abstract available

Publication types

  • News

MeSH terms

  • Androgen Antagonists / therapeutic use
  • Antineoplastic Agents, Hormonal / adverse effects
  • Antineoplastic Agents, Hormonal / therapeutic use
  • Humans
  • Male
  • Prostatic Neoplasms* / radiotherapy

Substances

  • Androgen Antagonists
  • Antineoplastic Agents, Hormonal